Gene Editing Patent Application Trends 2024

Gene Editing patent applications in 2024

Top Technology Areas in Gene Editing

Top CPC Codes

• C12N9/22 (No explanation available)
  • Count: 189 patents
  • Example: 20240226152. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING simplified abstract (Wisconsin Alumni Research Foundation)
• C12N2310/20 (No explanation available)
  • Count: 181 patents
  • Example: 20240226246. NOVEL OMNI-50 CRISPR NUCLEASE simplified abstract (EmendoBio Inc.)
• C12N15/11 (No explanation available)
  • Count: 102 patents
  • Example: 20240226152. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING simplified abstract (Wisconsin Alumni Research Foundation)
• C12N15/907 (No explanation available)
  • Count: 63 patents
  • Example: 20240226246. NOVEL OMNI-50 CRISPR NUCLEASE simplified abstract (EmendoBio Inc.)
• C12N2800/80 (No explanation available)
  • Count: 55 patents
  • Example: 20240226246. NOVEL OMNI-50 CRISPR NUCLEASE simplified abstract (EmendoBio Inc.)
• C12N15/102 (No explanation available)
  • Count: 46 patents
  • Example: 20240228546. METHODS AND PRODUCTS FOR GENETIC ENGINEERING simplified abstract (Institut National De La Sante Et De La Recherche Medicale (INSERM))
• C12N15/113 (No explanation available)
  • Count: 46 patents
  • Example: 20240228546. METHODS AND PRODUCTS FOR GENETIC ENGINEERING simplified abstract (Institut National De La Sante Et De La Recherche Medicale (INSERM))
• C12N15/86 (No explanation available)
  • Count: 43 patents
  • Example: 20240226334. CORRECTION OF DUCHENNE MUSCULAR DYSTROPHY MUTATIONS WITH ALL-IN-ONE ADENO-ASSOCIATED VIRUS-DELIVERED SINGLE-CUT CRISPR simplified abstract (The Board of Regents of The University of Texas System)
• C12N15/111 (No explanation available)
  • Count: 38 patents
  • Example: 20240226334. CORRECTION OF DUCHENNE MUSCULAR DYSTROPHY MUTATIONS WITH ALL-IN-ONE ADENO-ASSOCIATED VIRUS-DELIVERED SINGLE-CUT CRISPR simplified abstract (The Board of Regents of The University of Texas System)
• A61K48/005 (No explanation available)
  • Count: 29 patents
  • Example: 20240226327. EFFECTOR PROTEINS, EFFECTOR PARTNERS, COMPOSITIONS, SYSTEMS AND METHODS OF USE THEREOF simplified abstract (Mammoth Biosciences, Inc.)

Top Companies in Gene Editing

The Broad Institute, Inc.

• Number of Gene Editing patents: 17
• Top CPC codes:
  • C12N9/22 (No explanation available): 13 patents
  • C12N2310/20 (No explanation available): 13 patents
  • C12N15/907 (No explanation available): 9 patents
• Recent patents:
  • 20240084287. SINGLE CELL CELLULAR COMPONENT ENRICHMENT FROM BARCODED SEQUENCING LIBRARIES simplified abstract (The Broad Institute, Inc.) (20240314)
  • 20240084364. CRISPR ENZYMES AND SYSTEMS simplified abstract (The Broad Institute, Inc.) (20240314)
  • 20240047011. METHODS FOR IDENTIFYING NOVEL GENE EDITING ELEMENTS simplified abstract (The Broad Institute, Inc.) (20240208)

Mammoth Biosciences, Inc.

• Number of Gene Editing patents: 8
• Top CPC codes:
  • C12N15/11 (No explanation available): 5 patents
  • C12N9/22 (No explanation available): 5 patents
  • C12N2310/20 (No explanation available): 5 patents
• Recent patents:
  • 20240191281. PROGRAMMABLE NUCLEASES AND METHODS OF USE simplified abstract (Mammoth Biosciences, Inc.) (20240613)
  • 20240084275. COMPOSITIONS AND METHODS OF USING PROGRAMMABLE NUCLEASES FOR INDUCING CELL DEATH simplified abstract (Mammoth Biosciences, Inc.) (20240314)
  • 20240218393. VECTORS ENCODING GENE EDITING SYSTEMS AND USES THEREOF simplified abstract (Mammoth Biosciences, Inc.) (20240704)

Massachusetts Institute of Technology

• Number of Gene Editing patents: 6
• Top CPC codes:
  • C12N9/22 (No explanation available): 6 patents
  • C12N2310/20 (No explanation available): 5 patents
  • C12N15/111 (No explanation available): 4 patents
• Recent patents:
  • 20240132883. RNA-TRIGGERED PROTEIN CLEAVAGE AND APPLICATIONS BY THE CRISPR CAS7-11-CSX29 COMPLEX simplified abstract (Massachusetts Institute of Technology) (20240425)
  • 20240067961. SYSTEMS, METHODS, AND COMPOSITIONS FOR SITE-SPECIFIC GENETIC ENGINEERING USING PROGRAMMABLE ADDITION VIA SITE-SPECIFIC TARGETING ELEMENTS (PASTE) simplified abstract (Massachusetts Institute of Technology) (20240229)
  • 20240035031. TARGETED TRANS-SPLICING USING CRISPR/CAS13 simplified abstract (Massachusetts Institute of Technology) (20240201)

Scribe Therapeutics Inc.

• Number of Gene Editing patents: 6
• Top CPC codes:
  • C12N2310/20 (No explanation available): 6 patents
  • C12N9/22 (No explanation available): 5 patents
  • C12N15/907 (No explanation available): 4 patents
• Recent patents:
  • 20240033377. AAV VECTORS FOR GENE EDITING simplified abstract (Scribe Therapeutics Inc.) (20240201)
  • 20240026385. ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS simplified abstract (Scribe Therapeutics Inc.) (20240125)
  • 20240026386. COMPOSITIONS AND METHODS FOR THE TARGETING OF BCL11A simplified abstract (Scribe Therapeutics Inc.) (20240125)

THE BROAD INSTITUTE, INC.

• Number of Gene Editing patents: 6
• Top CPC codes:
  • C12N2310/20 (No explanation available): 5 patents
  • C12N9/22 (No explanation available): 4 patents
  • C12N15/102 (No explanation available): 3 patents
• Recent patents:
  • 20240018552. NOVEL CRISPR ENZYMES AND SYSTEMS simplified abstract (THE BROAD INSTITUTE, INC.) (20240118)
  • 20240110165. NOVEL TYPE VI CRISPR ORTHOLOGS AND SYSTEMS simplified abstract (THE BROAD INSTITUTE, INC.) (20240404)
  • 20240043828. T-DNA MEDIATED GENETIC MODIFICATION simplified abstract (THE BROAD INSTITUTE, INC.) (20240208)

UNIVERSITY OF MASSACHUSETTS

• Number of Gene Editing patents: 6
• Top CPC codes:
  • C12N9/22 (No explanation available): 4 patents
  • C12N2310/20 (No explanation available): 3 patents
  • C12N15/113 (No explanation available): 2 patents
• Recent patents:
  • 20240018479. METHODS AND COMPOSITIONS FOR TREATMENT OF MUSCLE DISEASE WITH IPSC-INDUCED HUMAN SKELETAL MUSCLE STEM CELLS simplified abstract (UNIVERSITY OF MASSACHUSETTS) (20240118)
  • 20240175056. PRIME EDITING-BASED SIMULTANEOUS GENOMIC DELETION AND INSERTION simplified abstract (UNIVERSITY OF MASSACHUSETTS) (20240530)
  • 20240167029. MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING simplified abstract (UNIVERSITY OF MASSACHUSETTS) (20240523)

The Regents of the University of California

• Number of Gene Editing patents: 5
• Top CPC codes:
  • C12N9/22 (No explanation available): 3 patents
  • C12N15/102 (No explanation available): 3 patents
  • C12N2310/20 (No explanation available): 3 patents
• Recent patents:
  • 20240093217. RICE SUBERIN BIOSYNTHETIC GENES AND REGULATORS simplified abstract (The Regents of the University of California) (20240321)
  • 20240023528. ONE-LOCUS INDUCIBLE PRECISION GUIDED STERILE INSECT TECHNIQUE OR TEMPERATURE-INDUCIBLE PRECISION GUIDED STERILE INSECT TECHNIQUE simplified abstract (The Regents of the University of California) (20240125)
  • 20240026321. CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (The Regents of the University of California) (20240125)

INBIOSE N.V.

• Number of Gene Editing patents: 5
• Top CPC codes:
  • C12P19/12 (No explanation available): 4 patents
  • C12N1/205 (No explanation available): 3 patents
  • C12N9/1081 (No explanation available): 3 patents
• Recent patents:
  • 20240035004. VARIANT SUCROSE PERMEASE POLYPEPTIDES simplified abstract (INBIOSE N.V.) (20240201)
  • 20240191270. FERMENTATIVE PRODUCTION simplified abstract (INBIOSE N.V.) (20240613)
  • 20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS simplified abstract (INBIOSE N.V.) (20240314)

Jiangnan University

• Number of Gene Editing patents: 5
• Top CPC codes:
  • C12N15/70 (No explanation available): 4 patents
  • C12P19/04 (No explanation available): 2 patents
  • C12N9/1051 (No explanation available): 2 patents
• Recent patents:
  • 20240060076. THERMAL SWITCH SYSTEM AND APPLICATION THEREOF IN IMPROVING YIELD OF AMINO ACID simplified abstract (Jiangnan University) (20240222)
  • 20240035057. Construction Method and Application of Microorganism Capable of Realizing High Production of Lacto-N-tetrose simplified abstract (Jiangnan University) (20240201)
  • 20240035058. Construction Method and Application of Microorganism Capable of Realizing High Production of Lacto-N-neotetraose simplified abstract (Jiangnan University) (20240201)

Regeneron Pharmaceuticals, Inc.

• Number of Gene Editing patents: 4
• Top CPC codes:
  • C12N9/22 (No explanation available): 3 patents
  • G16B25/00 (No explanation available): 2 patents
  • C12N15/907 (No explanation available): 2 patents
• Recent patents:
  • 20240052365. METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME simplified abstract (Regeneron Pharmaceuticals, Inc.) (20240215)
  • 20240093316. CAS-READY MOUSE EMBRYONIC STEM CELLS AND MICE AND USES THEREOF simplified abstract (Regeneron Pharmaceuticals, Inc.) (20240321)
  • 20240084293. CRISPR/CAS SCREENING PLATFORM TO IDENTIFY GENETIC MODIFIERS OF TAU SEEDING OR AGGREGATION simplified abstract (Regeneron Pharmaceuticals, Inc.) (20240314)

New Companies in Gene Editing (Last Month)

800px

No new companies detected in the last month.

Emerging Technology Areas in Gene Editing

• G06N3/088 (No explanation available)
  • Count: 1 patents
  • Example: 20240047011. METHODS FOR IDENTIFYING NOVEL GENE EDITING ELEMENTS simplified abstract (The Broad Institute, Inc.)
• G06F18/2413 (No explanation available)
  • Count: 1 patents
  • Example: 20240047011. METHODS FOR IDENTIFYING NOVEL GENE EDITING ELEMENTS simplified abstract (The Broad Institute, Inc.)
• G06F18/295 (No explanation available)
  • Count: 1 patents
  • Example: 20240047011. METHODS FOR IDENTIFYING NOVEL GENE EDITING ELEMENTS simplified abstract (The Broad Institute, Inc.)
• G06F18/231 (No explanation available)
  • Count: 1 patents
  • Example: 20240047011. METHODS FOR IDENTIFYING NOVEL GENE EDITING ELEMENTS simplified abstract (The Broad Institute, Inc.)
• G16B40/30 (No explanation available)
  • Count: 1 patents
  • Example: 20240047011. METHODS FOR IDENTIFYING NOVEL GENE EDITING ELEMENTS simplified abstract (The Broad Institute, Inc.)
• G16B40/00 (No explanation available)
  • Count: 1 patents
  • Example: 20240047011. METHODS FOR IDENTIFYING NOVEL GENE EDITING ELEMENTS simplified abstract (The Broad Institute, Inc.)
• C12N2310/317 (No explanation available)
  • Count: 1 patents
  • Example: 20240043840. CHEMICALLY MODIFIED CRISPR-CAS13 GUIDE RNAS simplified abstract (New York Genome Center, Inc.)
• C07K14/195 (No explanation available)
  • Count: 1 patents
  • Example: 20240043828. T-DNA MEDIATED GENETIC MODIFICATION simplified abstract (THE BROAD INSTITUTE, INC.)
• A61L2430/02 (No explanation available)
  • Count: 1 patents
  • Example: 20240043818. Engineered Cells for Increased Collagen Production simplified abstract (Northeastern University)
• A61L2430/16 (No explanation available)
  • Count: 1 patents
  • Example: 20240043818. Engineered Cells for Increased Collagen Production simplified abstract (Northeastern University)

Top Companies in Emerging Gene Editing Technologies

• The Broad Institute, Inc.: 6 patents
• Northeastern University: 2 patents
• THE BROAD INSTITUTE, INC.: 1 patents
• New York Genome Center, Inc.: 1 patents